Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free
- BOND RX™ Validated
- KO Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal TIA1 antibody. Carrier free. Suitable for IP, WB, IHC-P, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 1 publication.
View Alternative Names
Cytotoxic granule associated RNA binding protein TIA1, Nucleolysin TIA-1 isoform p40, RNA-binding protein TIA-1, T-cell-restricted intracellular antigen-1, p40-TIA-1, TIA-1, TIA1
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
This data was developed using ab263945, the same antibody clone in a different buffer formulation.
ab263945 was shown to react with TIA1 in wild-type HAP1 cells in immunocytochemistry with loss of signal observed in a TIA1 knockout cell line. ab263945 at 1/600 dilution.
These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
Immunohistochemical analysis of paraffin-embedded Human gastric cancer tissue labeling TIA1 with ab263945 at 1/4000 dilution (0.15ug/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining in tumor-infiltrating T-lymphocytes of human gastric cancer (PMID : 10658910) is observed.
The section was incubated with ab256492 for 15 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
Intracellular flow cytometric analysis of 4% paraformaldehyde fixed, 90% methanol permeabilized Jurkat (human T cell leukemia T lymphocyte) cells labelling TIA1 with ab263945 at 1/600 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor®488, ab150077) at 1/2000 dilution was used as the secondary antibody.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
Immunohistochemical analysis of paraffin-embedded Human classical hodgkin lymphoma tissue labeling TIA1 with ab263945 at 1/4000 dilution (0.15ug/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining in T-lymphocytes of human classical hodgkin lymphoma (PMID : 19096012) is observed.
The section was incubated with ab256492 for 15 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
Intracellular flow cytometric analysis of 4% paraformaldehyde fixed, 90% methanol permeabilized TIA1 knockout HAP1 (TIA1 knockout human chronic myelogenous leukemia near-haploid cell line, (Left) / WT HAP1 (Right) cells labelling TIA1 with ab263945 at 1/600 dilution (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat anti rabbit IgG (Alexa Fluor®488, ab150077) at 1/2000 dilution was used as the secondary antibody.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
Immunohistochemical analysis of paraffin-embedded Human spleen tissue labeling TIA1 with ab263945 at 1/4000 dilution (0.15ug/ml) followed by a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101). Positive staining in T-lymphocytes of human spleen (PMID : 23510456) is observed.
The section was incubated with ab256492 for 15 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Secondary antibody only control : Secondary antibody is a ready to use Rabbit specific IHC polymer detection kit HRP/DAB (ab209101).
Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution 2) for 20 mins.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
- IP
Unknown
Immunoprecipitation - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
TIA1 was immunoprecipitated from 0.35 mg HuT-78 (human Sezary syndrome cutaneous T lymphocyte) whole cell lysate with ab263945 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab263945 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : HuT-78 (human Sezary syndrome cutaneous T lymphocyte) whole cell lysate 10ug
Lane 2 : ab263945 IP in HuT-78 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab263945 in HuT-78 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 3 seconds.
Truncated form (~16kDa) of TIA1 was also immunoprecipitated. (PMID : 25224594).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
All lanes:
Immunoprecipitation - Anti-TIA1 antibody [EPR22999-80] (<a href='/en-us/products/primary-antibodies/tia1-antibody-epr22999-80-ab263945'>ab263945</a>)
Predicted band size: 43 kDa
Observed band size: 16 kDa,42 kDa,43 kDa
false
- IP
Unknown
Immunoprecipitation - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
TIA1 was immunoprecipitated from 0.35 mg Jurkat (human T cell leukemia T lymphocyte) whole cell lysate 10ug with ab263945 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab263945 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.
Lane 1 : Jurkat (human T cell leukemia T lymphocyte) whole cell lysate 10ug
Lane 2 : ab263945 IP in Jurkat whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab263945 in Jurkat whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 10 seconds.
Truncated form (~16kDa) of TIA1 was also immunoprecipitated. (PMID : 25224594).
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
All lanes:
Immunoprecipitation - Anti-TIA1 antibody [EPR22999-80] (<a href='/en-us/products/primary-antibodies/tia1-antibody-epr22999-80-ab263945'>ab263945</a>)
Predicted band size: 43 kDa
Observed band size: 16 kDa,42 kDa,43 kDa
false
- IP
Lab
Immunoprecipitation - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
This data was developed using ab263945, the same antibody clone in a different buffer formulation.
Immunoprecipitation of TIA1 in HAP1 cells. Lysates were prepared and immunoprecipitation was performed using 1.0 µg of 86050 pre-coupled to Protein A beads. Samples were then washed and processed for western blot.
These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Immunoprecipitation - Anti-TIA1 antibody [EPR22999-80] (<a href='/en-us/products/primary-antibodies/tia1-antibody-epr22999-80-ab263945'>ab263945</a>) at 1 µg
All lanes:
HAP1 cells
false
- WB
Lab
Western blot - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The molecular weight observed is consistent with what has been described in the literature (PMID : 30533021).
ab263945 was shown to specifically react with TIA1 in wild-type HAP1 cells as signal was lost in TIA1 knockout cells. Wild-type and TIA1 knockout samples were subjected to SDS-PAGE. ab263945 and ab181602 (Rabbit anti-GAPDH loading control) were incubated 1 hour at room temperature at 1/1000 dilution and 1/200,000 dilution respectively. Blots were developed with Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) secondary antibody at 1/100,000 dilution for 1 hour at room temperature before imaging. The blot was developed on a BIO-RAD® ChemiDoc™ MP instrument using the ECL technique.
Exposure time : Lanes 1-3 : 103 seconds Lane 4 : 26 seconds Lanes 5-6 : 103 seconds Lane 7 : 3 minutes.
This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (ab263945).
All lanes:
Western blot - Anti-TIA1 antibody [EPR22999-80] (<a href='/en-us/products/primary-antibodies/tia1-antibody-epr22999-80-ab263945'>ab263945</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
TIA1 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
Jurkat (human T cell leukemia T lymphocyte), whole cell lysate at 20 µg
Lane 4:
HuT-78 (human Sezary syndrome cutaneous T lymphocyte), whole cell lysate at 20 µg
Lane 5:
MOLT-4 (human lymphoblastic leukemia T lymphoblast), whole cell lysate at 20 µg
Lane 6:
K562 (human chronic myelogenous leukemia lymphoblast), whole cell lysate at 20 µg
Lane 7:
Human tonsil tissue lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 43 kDa
Observed band size: 42 kDa,43 kDa
false
- WB
Lab
Western blot - Anti-TIA1 antibody [EPR22999-80] - BSA and Azide free (AB263953)
This data was developed using ab263945, the same antibody clone in a different buffer formulation.
ab263945 was shown to react with TIA1 in wild-type HAP1 cells in Western blot with loss of signal observed in a TIA1 knockout cell line. Wild-type HAP1 and TIA1 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab263945 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-TIA1 antibody [EPR22999-80] (<a href='/en-us/products/primary-antibodies/tia1-antibody-epr22999-80-ab263945'>ab263945</a>) at 1/1000 dilution
Lane 1:
Wild-type HAP1 lysate at 50 µg
Lane 2:
TIA1 knock-out HAP1 lysate at 50 µg
false
Related conjugates and formulations (1)
-
Anti-TIA1 antibody [EPR22999-80]
Reactivity data
Product details
ab263953 is the carrier-free version of ab263945.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TIA1 functions in the assembly of stress granules which are aggregates of proteins and RNAs that form in response to cellular stress. It is part of a complex dynamic system that regulates mRNA translation by directing untranslated mRNAs to stress granules thereby influencing gene expression at the post-transcriptional level. TIA1 is implicated in apoptosis and can bind with other proteins like HuR to affect mRNA stability and translation.
Pathways
TIA1 participates in stress response signaling and apoptotic pathways. It is involved in the regulation of mRNA metabolism playing a critical role in the cellular stress response pathway by modulating the translation and stability of mRNAs during stress. TIA1 interacts with kinases like JNK to mediate these stress responses and works alongside related proteins including G3BP to organize mRNAs into stress granules.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Oncology research 30:289-300 PubMed37303493
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com